The Clinicopathological and Prognostic Significance of the Expression of PD-L1 and MET Genes in Breast Cancer: Potential Therapeutic Targets
The expression of the PD-L1 and MET genes is remarkably associated with worse tumor clinicopathologic features and poor prognosis in patients with breast cancer. Further investigations using combination drug regimens targeting PD-L1 and MET are important, particularly in breast tumors expressing high levels of both proteins.
Authors
- Nehad M. Ayoub (ORCID: https://orcid.org/0000-0003-2284-4370)
- Aymen Shatnawi (ORCID: https://orcid.org/0000-0001-6435-3727)
- Laith Naser AL-Eitan (ORCID: https://orcid.org/0000-0003-0064-0190)
- Moath Al-Shorman
- Muhsen Al-Diabat
Institutions
- Medical University of South Carolina (US)
- Jordan University of Science and Technology (JO)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2024-10-11
- DOI
- https://doi.org/10.2174/0115680096333231240902070108
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00